The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival

被引:98
|
作者
Garcia-Bermudez, Javier [1 ]
Cuezva, Jose M. [1 ]
机构
[1] Univ Autonoma Madrid, Ctr Invest Biomed Red Enfermedades Raras CIBER IS, Inst Invest Hosp 12 Octubre, Dept Biol Mol,Ctr Biol Mol Severo Ochoa,CSIC, E-28049 Madrid, Spain
来源
关键词
ATP synthase; ATPase Inhibitory Factor 1; Mitochondria; Cancer; ROS signaling; Nuclear reprogramming; DEPENDENT PROTEIN-KINASE; CYTOCHROME-C-OXIDASE; MITOCHONDRIAL ADENOSINE-TRIPHOSPHATASE; BETA-F1-ATPASE MESSENGER-RNA; RAT-LIVER; RESPIRATORY-CHAIN; CANCER-CELLS; OXIDATIVE-PHOSPHORYLATION; BIOENERGETIC SIGNATURE; ELECTRON-TRANSPORT;
D O I
10.1016/j.bbabio.2016.02.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this contribution we summarize most of the findings reported for the molecular and cellular biology of the physiological inhibitor of the mitochondrial H+-ATP synthase, the engine of oxidative phosphorylation (OXPHOS) and gate of cell death. We first describe the structure and major mechanisms and molecules that regulate the activity of the ATP synthase placing the ATPase Inhibitory Factor 1 (IF1) as a major determinant in the regulation of the activity of the ATP synthase and hence of OXPHOS. Next, we summarize the post transcriptional mechanisms that regulate the expression of IF1 and emphasize, in addition to the regulation afforded by the protonation state of histidine residues, that the activity of IF1 as an inhibitor of the ATP synthase is also regulated by phosphorylation of a serine residue. Phosphorylation of S39 in IF1 by the action of a mitochondrial cAMP-dependent protein kinase A hampers its interaction with the ATP synthase, i.e., only dephosphorylated IF1 interacts with the enzyme. Upon IF1 interaction with the ATP synthase both the synthetic and hydrolytic activities of the engine of OXPHOS are inhibited. These findings are further placed into the physiological context to stress the emerging roles played by IF1 in metabolic reprogramming in cancer, in hypoxia and in cellular differentiation. We review also the implication of IF1 in other cellular situations that involve the malfunctioning of mitochondria. Special emphasis is given to the role of IF1 as driver of the generation of a reactive oxygen species signal that, emanating from mitochondria, is able to reprogram the nucleus of the cell to confer by various signaling pathways a cell-death resistant phenotype against oxidative stress. Overall, our intention is to highlight the urgent need of further investigations in the molecular and cellular biology of IF1 and of its target, the ATP synthase, to unveil new therapeutic strategies in human pathology. This article is part of a Special Issue entitled 'EBEC 2016: 19th European Bioenergetics Conference, Riva del Garda, Italy, July 2-6, 2016', edited by Prof. Paolo Bernardi. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:1167 / 1182
页数:16
相关论文
共 50 条
  • [31] Binding of the Inhibitor Protein IF1 to Bovine F1-ATPase
    Biason, John V.
    Runswick, Michael J.
    Fearnley, Ian M.
    Walker, John E.
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 406 (03) : 443 - 453
  • [32] Regulator of Calcineurin 1 (RCAN1): A New Factor in the Control of Mitochondrial Dynamics, Metabolism, and Cardiomyocyte Survival
    Parra, Valentina
    Rotter, David
    Pedrozo, Zully
    Rothermel, Beverly A.
    CIRCULATION, 2013, 128 (22)
  • [33] Mitochondrial morphology and metabolism in pancreatic β-cell form IF1 KO mice
    Bazila, B.
    Jezek, P.
    Dlaskova, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53
  • [34] Functional transitions of F0F1-ATPase mediated by the inhibitory peptide IF1 in yeast coupled submitochondrial particles
    Galkin, M
    Venard, R
    Vaillier, J
    Velours, J
    Haraux, F
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (10): : 1963 - 1970
  • [35] The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review
    Maierean, Serban
    Serban, Maria-Corina
    Rizzo, Manfredi
    Lippi, Giuseppe
    Sahebkar, Amirhossein
    Banach, Maciej
    LIPIDS IN HEALTH AND DISEASE, 2017, 16 : 1 - 7
  • [36] RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease
    Mandigo, Amy C.
    Yuan, Wei
    Xu, Kexin
    Gallagher, Peter
    Pang, Angel
    Guan, Yi Fang
    Shafi, Ayesha A.
    Thangavel, Chellappagounder
    Sheehan, Beshara
    Bogdan, Denisa
    Paschalis, Alec
    McCann, Jennifer J.
    Laufer, Talya S.
    Gordon, Nicolas
    Vasilevskaya, Irina A.
    Dylgjeri, Emanuela
    Chand, Saswati N.
    Schiewer, Matthew J.
    Domingo-Domenech, Josep
    Den, Robert B.
    Holst, Jeff
    McCue, Peter A.
    de Bono, Johann S.
    McNair, Christopher
    Knudsen, Karen E.
    CANCER DISCOVERY, 2021, 11 (09) : 2334 - 2353
  • [37] Degradation of IF1 controls energy metabolism during osteogenic differentiation of stem cells
    Sanchez-Arago, Maria
    Garcia-Bermudez, Javier
    Martinez-Reyes, Inmaculada
    Santacatterina, Fulvio
    Cuezva, Jose M.
    EMBO REPORTS, 2013, 14 (07) : 638 - 644
  • [38] The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review
    Serban Maierean
    Maria-Corina Serban
    Manfredi Rizzo
    Giuseppe Lippi
    Amirhossein Sahebkar
    Maciej Banach
    Lipids in Health and Disease, 16
  • [39] The Inhibitor Protein (IF1) of the F1F0-ATPase Modulates Human Osteosarcoma Cell Bioenergetics
    Barbato, Simona
    Sgarbi, Gianluca
    Gorini, Giulia
    Baracca, Alessandra
    Solaini, Giancarlo
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (10) : 6338 - 6348
  • [40] Control of Mitochondrial Remodeling by the ATPase Inhibitory Factor 1 Unveils a Pro-survival Relay via OPA1
    Faccenda, Danilo
    Nakamura, Junji
    Gorini, Giulia
    Dhoot, Gurtej K.
    Piacentini, Mauro
    Yoshida, Masusuke
    Campanella, Michelangelo
    CELL REPORTS, 2017, 18 (08): : 1869 - 1883